Stocks
Amplia Therapeutics LimitedINNMF
OQBHealthcareBiotechnology$0.18
A clinical-stage biotechnology company focused on developing small‑molecule inhibitors targeting focal adhesion kinase (FAK) for the treatment of cancer and fibrotic diseases. Its lead drug candidates are being studied in clinical trials, including combinations aimed at improving outcomes in pancrea...
52W Range: $0.03 – $0.27
Congressional Interest in Amplia Therapeutics Limited (INNMF)
2 members of Congress have disclosed 2 trades in Amplia Therapeutics Limited (INNMF), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
2
Sells
0
Who in Congress Is Trading INNMF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-04-21 | Jared Polis | buy | $50K – $100K |
| 2010-04-02 | JAMES B. RENACCI | buy | $741.95 |